Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Global Paternity & Relationship Testing Services Market Research Report 2023-2027: Instrumentation, Automation & Diagnostic Trends Shaping the Future of Relationship Testing



DUBLIN, Oct. 23, 2023 /PRNewswire/ – The “Paternity & Relationship Testing Services. Global Market Forecasts for Applications and Technologies with Executive and Consultant Guides. 2023 to 2027” report has been added to ResearchAndMarkets.com’s offering. This is a complex area, but this…

TAR-200 Intravesical Delivery System Results Show 77 Percent Complete Response Rate in Patients with Bacillus-Calmette-Guérin Unresponsive, High-Risk Non-Muscle-Invasive Bladder Cancer


Phase 2b SunRISe-1 study results showed sustained, durable complete responses beyond one year with intravesical gemcitabine delivery system MADRID, Oct. 22, 2023 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that data from the Phase 2b SunRISe-1…

The Holocaust Remembrance Association Works to Uphold the Truth About the Holocaust and Violence Against the Jewish People


The extent of their brutality knew no bounds, as they resorted to mass kidnappings and subjected their victims to public humiliation, marching them through the streets. The catalog of atrocities seems endless.

As we grapple with the weight of this tragedy, it’s important to remember that thousands of Israelis, along with an as yet uncertain number of citizens from other nations, are dead, wounded, or have been taken hostage. Among the affected, it has been reported that dozens of Americans are also among the victims. Our hearts ache for the lives lost and the families forever changed by this appalling event.

The ongoing crisis in Israel serves as a stark reminder of the Holocaust Garden of Hope’s vital role in safeguarding the truth of the Holocaust. Right now, the world is witnessing the consequences of a troubling pattern of denying and rewriting the history of the Holocaust, as millions continue to deny the Holocaust and the legitimacy of the Jewish nation.

That is why now more than ever, for such a time as this, the need for education about the Holocaust is underscored by the urgency of the moment. The Holocaust Remembrance Association, formed by Jewish descendants of Holocaust survivors and Christian allies works to preserve the truth of the Holocaust and facilitates education, healing, and reconciliation, all to send an undeniable message to the world – never again.

The Holocaust Remembrance Association is a 501(c)(3) educational organization based in Kingwood, Texas, formed by Jewish descendants of Holocaust survivors and Christian allies in order to sensitize hearts to the issues of the Holocaust and facilitate education, healing, and reconciliation.

For interviews, please contact Basya Benshushan (832) 331-3908 to schedule.

Media Contact

Basya Benshushan, Holocaust Remembrance Association, 1 (832) 331-3908, [email protected], https://holocaustremembranceassociation.org/

SOURCE Holocaust Remembrance Association

Lilly's Retevmo® (selpercatinib) Phase 3 Results in RET Fusion-Positive Non-Small Cell Lung Cancer and RET-Mutant Medullary Thyroid Cancer Both Published in The New England Journal of Medicine and Presented in a Presidential Symposium at ESMO Congress 2023



– In the Phase 3 LIBRETTO-431 study, Retevmo more than doubled progression-free survival (PFS) compared to chemotherapy plus pembrolizumab in patients with advanced or metastatic rearranged during transfection (RET) fusion-positive non-small cell lung cancer (NSCLC) – In the Phase 3…

New Data from Phase 3 PAPILLON Study Show RYBREVANT® (amivantamab-vmjw) Plus Chemotherapy Resulted in 60 Percent Reduction in Risk of Disease Progression or Death in Patients with Previously Untreated EGFR Exon 20 Insertion Mutation-Positive Non-Small Cell Lung Cancer



Data show the potential impact of RYBREVANT® and chemotherapy combination as first-line treatment for patients with advanced non-small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations Late-breaking data presented in a Presidential Symposium at 2023 ESMO Congress and…